Genesis Therapeutics

Genesis Therapeutics is a biotechnology company that focuses on using artificial intelligence to accelerate drug discovery and development. The company employs a team of drug researchers, deep learning experts, and software engineers to create advanced molecular AI platforms. 

Exscientia

Exscientia is a pioneering pharmaceutical company that leverages artificial intelligence to revolutionize drug discovery and development. The company focuses on creating precision-designed drugs using advanced AI algorithms and machine learning techniques.

Evaxion Biotech

Evaxion Biotech is a biotechnology company that specializes in developing vaccines using artificial intelligence. Their proprietary AI platform is designed to identify potential vaccine targets for both cancer and infectious diseases.

Envisagenics

Envisagenics is an AI-driven biotechnology company that specializes in RNA splicing research and therapeutic development. They use their proprietary platform, which combines artificial intelligence and machine learning, to analyze RNA sequencing data and identify novel RNA splicing variants associated with diseases.

AcuraStem

AcuraStem is a biotechnology company focused on developing innovative treatments for neurodegenerative diseases, including ALS and frontotemporal dementia. Utilizing its proprietary iNeuroRx® platform, AcuraStem creates patient-derived disease models that accurately reflect the complexities of these conditions. By integrating advanced AI techniques, the company aims to identify effective therapeutics tailored to individual patient needs, enhancing the potential for successful treatment outcomes in neurodegeneration.

Verge Genomics

Verge Genomics is a biotechnology company that uses artificial intelligence and human genomic data to discover and develop new drugs for complex diseases. They have a proprietary platform called that analyzes patient tissue data to identify potential drug targets.

Tempus

Tempus is a technology company that applies artificial intelligence to healthcare data. They analyze clinical and molecular information, including DNA, RNA, and pathology images, to advance precision medicine.

Simulations Plus

Simulations Plus develops software and leverages AI and machine learning for drug discovery and development, focusing on modeling and simulation tools. Their products include GastroPlus for pharmacokinetics, ADMET Predictor for molecular property prediction, and DDDPlus for dissolution analysis. The company offers solutions for physiologically-based pharmacokinetics, quantitative systems pharmacology, and population PK/PD modeling. They also provide consulting services to support pharmaceutical research, clinical trials, and regulatory submissions, helping clients improve drug development efficiency and success rates.

Schrödinger

Schrödinger is a technology company that develops computational software for drug discovery and materials science. Their platform uses physics-based modeling to simulate molecular behavior, enabling researchers to explore billions of potential drug candidates efficiently.

PrecisionLife

PrecisionLife is a precision medicine company that uses advanced analytics and AI to uncover disease mechanisms in complex chronic conditions. They identify patient subgroups, discover novel drug targets, and develop personalized treatments.